FDA
approval
· 2018-11-30
FDA Approved: ETODOLAC — Original Application (Chartwell RX, LLC)
Summary
The FDA approved Chartwell RX, LLC's etodolac as a generic (ANDA 209888) for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ETODOLAC (ETODOLAC)